These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 8529528

  • 1. The influence of antineoplaston A5 on particular subtypes of central dopaminergic receptors.
    Juszkiewicz M, Chodkowska A, Burzynski SR, Mlynarczyk M, Kleinrok Z.
    Drugs Exp Clin Res; 1995; 21(4):153-6. PubMed ID: 8529528
    [Abstract] [Full Text] [Related]

  • 2. The influence of antineoplaston A5 on the central dopaminergic structures.
    Juszkiewicz M, Chodkowska A, Burzynski SR, Feldo M, Majewska B, Kleinrok Z.
    Drugs Exp Clin Res; 1994; 20(4):161-7. PubMed ID: 7813388
    [Abstract] [Full Text] [Related]

  • 3. Prediction of drug-induced catalepsy based on dopamine D1, D2, and muscarinic acetylcholine receptor occupancies.
    Haraguchi K, Ito K, Kotaki H, Sawada Y, Iga T.
    Drug Metab Dispos; 1997 Jun; 25(6):675-84. PubMed ID: 9193868
    [Abstract] [Full Text] [Related]

  • 4. Effects of buspirone on dopamine dependent behaviours in rats.
    Dhavalshankh AG, Jadhav SA, Gaikwad RV, Gaonkar RK, Thorat VM, Balsara JJ.
    Indian J Physiol Pharmacol; 2007 Jun; 51(4):375-86. PubMed ID: 18476392
    [Abstract] [Full Text] [Related]

  • 5. Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs.
    Tidey JW, Bergman J.
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1163-74. PubMed ID: 9618419
    [Abstract] [Full Text] [Related]

  • 6. Effects of dextromethorphan on dopamine dependent behaviours in rats.
    Gaikwad RV, Gaonkar RK, Jadhav SA, Thorat VM, Jadhav JH, Balsara JJ.
    Indian J Exp Biol; 2007 Aug; 45(8):712-9. PubMed ID: 17877148
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms for metoclopramide-mediated sensitization and haloperidol-induced catalepsy in rats.
    Agovic MS, Yablonsky-Alter E, Lidsky TI, Banerjee SP.
    Eur J Pharmacol; 2008 Jun 10; 587(1-3):181-6. PubMed ID: 18457824
    [Abstract] [Full Text] [Related]

  • 8. Specific involvement of striatal D1 and D2 dopamine receptors in the neuroleptic catalepsy in rats.
    Wardas J, Pietraszek M, Ossowska K, Wolfarth S.
    Pol J Pharmacol; 1995 Jun 10; 47(4):349-53. PubMed ID: 8616516
    [Abstract] [Full Text] [Related]

  • 9. [The influence of calcium channel blockers on the effects of haloperidol and phenamine in mice and rats].
    Kozlovskiĭ VL, Prakh'e IV, Kenunen OG.
    Eksp Klin Farmakol; 1996 Jun 10; 59(3):12-5. PubMed ID: 8974575
    [Abstract] [Full Text] [Related]

  • 10. A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194.
    Audinot V, Newman-Tancredi A, Gobert A, Rivet JM, Brocco M, Lejeune F, Gluck L, Desposte I, Bervoets K, Dekeyne A, Millan MJ.
    J Pharmacol Exp Ther; 1998 Oct 10; 287(1):187-97. PubMed ID: 9765337
    [Abstract] [Full Text] [Related]

  • 11. D2 dopamine antisense RNA expression vector, unlike haloperidol, produces long-term inhibition of D2 dopamine-mediated behaviors without causing Up-regulation of D2 dopamine receptors.
    Davidkova G, Zhou LW, Morabito M, Zhang SP, Weiss B.
    J Pharmacol Exp Ther; 1998 Jun 10; 285(3):1187-96. PubMed ID: 9618422
    [Abstract] [Full Text] [Related]

  • 12. Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat.
    Carta AR, Frau L, Pinna A, Pontis S, Simola N, Schintu N, Morelli M.
    Synapse; 2008 Jul 10; 62(7):524-33. PubMed ID: 18435422
    [Abstract] [Full Text] [Related]

  • 13. Dopaminergic and cholinergic interaction in cataleptic responses in mice.
    Ushijima I, Kawano M, Kaneyuki H, Suetsugi M, Usami K, Hirano H, Mizuki Y, Yamada M.
    Pharmacol Biochem Behav; 1997 Sep 10; 58(1):103-8. PubMed ID: 9264077
    [Abstract] [Full Text] [Related]

  • 14. Roxindole: psychopharmacological profile of a dopamine D2 autoreceptor agonist.
    Bartoszyk GD, Harting J, Minck KO.
    J Pharmacol Exp Ther; 1996 Jan 10; 276(1):41-8. PubMed ID: 8558454
    [Abstract] [Full Text] [Related]

  • 15. Catalepsy induced by a blockade of dopamine D1 or D2 receptors was reversed by a concomitant blockade of adenosine A(2A) receptors in the caudate-putamen of rats.
    Hauber W, Neuscheler P, Nagel J, Müller CE.
    Eur J Neurosci; 2001 Oct 10; 14(8):1287-93. PubMed ID: 11703457
    [Abstract] [Full Text] [Related]

  • 16. In vitro and in vivo characterization of F-97013-GD, a partial 5-HT1A agonist with antipsychotic- and antiparkinsonian-like properties.
    Zazpe A, Artaiz I, Innerárity A, Del Olmo E, Castro E, Labeaga L, Pazos A, Orjales A.
    Neuropharmacology; 2006 Jul 10; 51(1):129-40. PubMed ID: 16643965
    [Abstract] [Full Text] [Related]

  • 17. Effects of dopamine D1 ligands on eye blinking in monkeys: efficacy, antagonism, and D1/D2 interactions.
    Jutkiewicz EM, Bergman J.
    J Pharmacol Exp Ther; 2004 Dec 10; 311(3):1008-15. PubMed ID: 15292458
    [Abstract] [Full Text] [Related]

  • 18. Dopamine receptor-mediated regulation of RGS2 and RGS4 mRNA differentially depends on ascending dopamine projections and time.
    Taymans JM, Kia HK, Claes R, Cruz C, Leysen J, Langlois X.
    Eur J Neurosci; 2004 Apr 10; 19(8):2249-60. PubMed ID: 15090051
    [Abstract] [Full Text] [Related]

  • 19. Modulation by group I mGLU receptor activation and group III mGLU receptor blockade of locomotor responses induced by D1-like and D2-like receptor agonists in the nucleus accumbens.
    Rouillon C, Degoulet M, Chevallier K, Abraini JH, David HN.
    Brain Res; 2008 Mar 10; 1198():44-54. PubMed ID: 18261716
    [Abstract] [Full Text] [Related]

  • 20. Long-lasting resistance to haloperidol-induced catalepsy in male rats chronically treated with caffeine.
    Góngora-Alfaro JL, Moo-Puc RE, Villanueva-Toledo JR, Alvarez-Cervera FJ, Bata-García JL, Heredia-López FJ, Pineda JC.
    Neurosci Lett; 2009 Oct 09; 463(3):210-4. PubMed ID: 19654037
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.